Select Page

CNBC: Walter Isaacson, a participant in Pfizer’s coronavirus vaccine trial, said he was thrilled to learn of the strong efficacy data announced by the pharmaceutical giant. “I feel great. And I feel really great for the country and the world and for Pfizer.”